DOCSLIB.ORG

R-Factors in Calcutta Strains of Vibrio Cholerae and Members of the Enterobacteriaceae by L

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
R-Factors in Calcutta Strains of Vibrio Cholerae and Members of the Enterobacteriaceae by L R-FACTORS IN CALCUTA STRAINS OF VIBRIO CHOLERAE AND ENTEROBACTERIACEAE 971 R-Factors in Calcutta Strains of Vibrio cholerae and Members of the Enterobacteriaceae by L. M. PRESCOTT, Scientist, WHO Cholera Team, Calcutta, India, A. DATrA, Research Officer. Indian Council of Medical Research, Cholera Research Centre, Calcutta, and G. C. DArrA, Research Assistant, Indian Council ofMedical Research, Cholera Research Centre, Calcutta In 1959, several Japanese investigators a, 1' dis- The strains called V. cholerae, biotype El Tor covered that multiple-drug-resistance was transferred (sometimes referred to as " atypical " V. cholerae by an episomal character known as the resistance or Vibrio eltor), were non-haemolytic, chicken- transfer factor (RTF). R-factors (RTF plus specific cell-agglutination-positive, cholera-phage-IV-resis- genes for drug-resistance) have since been isolated in tant, and polymyxin-B-resistant (10 ,ug). The Shi- many countries: Germany,c the Philippines,, Eng- gella strains were kindly made available by Dr Ranjit land,e Israel f and the USA. Fragmentary references Sen, All-India Institute ofHygiene and Public Health, have been made to the experimental transfer of Calcutta, India. The other Enterobacteriaceae R-factors from Shigella and Salmonella to Vibrio strains were made available by Dr S. Gorbach, cholerae.h 4 The present study was designed to Johns Hopkins Center for Medical Research and screen Calcutta strains of V. cholerae and members Training, School of Tropical Medicine, Calcutta, of the Enterobacteriaceae for the naturally occurring India. The R-factor-containing strain of Escherichia presence of R-factors, and also to corroborate coli, CSH-2 (222), was obtained from Dr T. Wata- previous findings by transferring R-factors from nabe, Keio University, Tokyo, Japan. members of the Enterobacteriaceae to V. cholerae, Methods. When examining the phenomenon of from V. cholerae to V. cholerae, and from V. cholerae episome-mediated transfer of multiple-drug-resist- to members of the Enterobacteriaceae. ance, preliminary ranges of sensitivity for donors and recipients were defined by testing the organisms Material and methods against low, medium and high concentrations of Strains. Altogether, 225 strains of V. cholerae and antimicrobial sensitivity discs (Difco). Tetracycline V. cholerae, biotype El Tor, isolated at the Cholera (Tc), streptomycin (Sm), chloramphenicol (Cm) and Research Centre, Calcutta, from hospital cases, erythromycin (Em) were tested on nutrient agar latrine samples and carriers, were screened for the (Difco) plates, while sulfadiazine (Su) and Triple- presence of R-factors. These strains were character- sulfonamide (Ts) were tested on Mueller-Hinton ized at the time of isolation.1' k A battery of bio- medium (Difco) plates. chemical and serological tests was repeated at the Cultures of donor and recipient strains (0.1 ml of time of this study to prove that no loss of charac- 6-hour brain-heart infusion (BHI) broth (Difco)) ters had occurred during holding in stock culture. were mixed and inoculated into 1 ml of BHI broth. The cultures were incubated for 18 hours at 37°C a Ochiai, K., Yamanaka, T., Kimura, K. & Sawada, 0. and plated on antibiotic-containing medium which (1959) Nippon Iji Shinpo, 1835, 38-42. b Watanabe, T. & Fukasawa, F. (1961) J. Bact., 81, 669. was differential for the recipient; bile salt agar (BSA) 'Lebek, G. (1963) Zbl. Bakt., L Abt. Orig., 188, 444-505. with Sm, Cm or Tc for vibrios and lactose broth dKuwahara, S. Goto, S., Kimura, M. & Abe, H. (1967) agar (LBA) containing Sm, Cm or Tc for members Bull. Wld Hlth Org., 37, 763, 771. of the Enterobacteriaceae. Colonies ' Datta, N. (1962) J. Hyg. (Lond.), 60, 301-310. displaying drug- f Marberg, K., Altmann, G. & Eshkol-Bruck, A. (1958) resistance were picked and examined serologically Amer. J. trop. Med. Hyg., 7, 51-57. and biochemically. Disc sensitivity tests were U Falkow, S. (1965) Amer. J. Med., 39, 753-765. repeated to establish further the passage of R-factors A Baron, L. S. & Falkow, S. (1961) Genetics, 46, 849. 4Kuwahara, S., Akiba, T., Koyama, K. & Arai, T. (1963) from donor to recipient. Jap. J. Microbiol., 7, 61. When surveying for naturally occurring R-factors, a De, S. P., Ghosh, A. K. & Shrivastava, D. L. (1965) strains showing patterns of drug-resistance after disc Indian J. med. Res., 53, 614-622. k Sinha, R., Deb, B. C., De, S. P., Abou-Gareeb, A. H.-& sensitivity tests were examined according to the Shrivastava, D. L. (1967) Bull. Wld Hlth Org., 37, 89-100. above procedures. 2274K 972 NOTES R-FACTOR SURVEY OF CALCUTTA STRAINS OF VIBRIO CHOLERAE AND MEMBERS OF THE ENTEROBACTERIACEAE Donor | Strains Strains with Strains R-factor a strain _________________organism examined|eamine1 multiple-drug-resistance R-factorspassing Recipient Vibrio cholerei 65 3 2 Su, Ts, EM, Tc (1) Proteus vulgaris 2 Vibrio cholerae, biotype El Tor 160 5 2 Su, Ts, Em, Tc (1) Proteus vulgaris 2 Su, Ts, Tc (1) Escherichia coli 6 6 4 Su, Ts, Em, Tc (3) Vibrio cholerae NIH 41 Su, Em, Tc (1) Enterobacter aerogenes 4 3 3 Su, Ts, Em, Tc (3) Vibrio cholerae NIH 41 Enterobacter cloacae 1 1 1 Su, Em, Tc (1) Vibrio cholerae NIH 41 Klebsiella pneumoniae 2 1 1 Su, Ts, Em, Tc (1) Vibrio cho/erae NIH 41 Shigelia flexneri 14 5 2 Su, Ts, Em, Sm (2) Klebsiella pneumoniae 49a Shigella boydii 7 7 7 Su, Ts, Em, Sm (7) Klebsiella pneumoniae 49a Shigella dysenteriae 3 0 0 Shlge/la sonnei 1 1 1 Su, Ts, Em, Sm (1) K/lebsiel/a pneumonlae 49a a Su = sulfadiazine, Ts= Triplesulfonamide, Em= erythromycin, Sm = streptomycin, Tc = tetracycline. The numbers in parentheses indicate the number of strains that have R-factors as listed. Results R-factor was the same in all 10 strains (Su, Ts, Em Episome-mediated transfer of drug-resistance. The Sm). Of the other 13 strains of Enterobacteriaceae original R-factor (Su, Sm, Cm, Tc) was passed from studied, 7 contained the R-factor (Su, Ts, Em, Tc) Escherichia coli CSH-2(222) to V. cholerae. Re- while 2 had segregants of this R-factor (Su, Em, Tc) transmission was then carried out from vibrio to (see accompanying table). vibrio, vibrio to Proteus vulgaris or vibrio to E. coli. Discussion Tertiary transmission was also achieved from P. vulgaris to vibrio. In contrast to Kuwahara's It can be seen from the experimental data that received the R-factor R-factors can pass back and forth quite easily studies, all organisms which between members of the Enterobacteriaceae and retained it at the same high level of resistance as in vibrios. At the same time, the data in the table the parent E. coli strain. Vibrios held the R-factors show that some members of the Enterobacteriaceae as long as they were grown on antibiotic-containing carry the same R-factors as the vibrios. It is possible media. After 4 or 5 passages on nutrient agar, the to surmise, therefore, that the R-factor is being R-factors were lost. P. vulgaris and E. coli, after passed from one group to the other. acquiring the R-factors from V. cholerae, appear to It is also interesting to note that, although the retain them at the initial high level of resistance shigellae which did contain R-factors all carried indefinitely, regardless of the medium used. resistance to Sm, the 3 strains of S. flexneri which Survey ofnaturally occurring R factors in Calcutta did not pass R-factors did contain, however, strains of vibrios and members of the Enterobacteria- multiple-drug-resistance to Su, Ts, Em and Tc. ceae. Of 225 vibrios examined, 4 strains were found Spontaneous segregants, as described by Wata- to contain R-factors. One strain of V. cholerae nabe,' also appeared in Calcutta strains. These and 1 strain of V. cholerae, biotype El Tor, had segregants were either (Su, Ts, Tc) or (Su, Em, Tc). the R-factor (Su, Ts, Em, Tc). The other 2 organ- They, just like the complete R-factor, could transfer isms, an El Tor vibrio and a V. cholerae strain, their resistance by conjugation. contained a segregant of this R-factor (Su, Ts, Tc). The appearance of R-factors in Calcutta strains of Altogether, 25 strains of shigellae were examined and 10 strains were found to have R-factors. The Watanabe, T. (1963) Bact. Rev., 27, 87-115. PERORAL TRANSMISSION OF COXIELLA BURNETI TO SMALL RODENTS 973 V. cholerae does not pose a major problem to the for survival as sensitive strains are eradicated. treatment of cholera at present. The possibility does Public health laboratories, therefore, should be made arise, however, that, since tetracycline is the drug of aware of this possibility, so that continued sur- choice in the treatment of cholera, those strains with veillance of the changing patterns of drug sensitivity multiple-drug-resistance may be selectively chosen is maintained from year to year. Elimination of Coxiella burneti in Faeces and the Transmission of this Agent to Small Rodents by the Peroral Route by P. At, J. RiEHAMEK and R. BREZINA, Institute oJ Virology, Czechoslovak Academy of Sciences, WHO Regional Reference Centre for Human Rickettsiosis, Bratislava, Czechoslovakia In the course of investigations into foci of Q-fever dosage of 105 EID50 contained in 0.2 ml of suspen- in Slovakia, antibodies against Coxiella burneti were sion. detected in the sera of the small rodents Clethrio- From 9 to 29 days after the infection the faeces nomys glareolus and Apodemus flavicollis. were collected at 2-day intervals. From these sam- The reason for our study was to explain the ples, suspensions were prepared and centrifuged and relationship between C. burneti and infected animals 0.5 ml of the suspension was injected intraperitoneal- in the foci, and to determine mechanisms of infec- ly into 3-5-g white mice.
Load more

Recommended publications
  • Parinaud's Oculoglandular Syndrome
    Tropical Medicine and Infectious Disease Case Report Parinaud’s Oculoglandular Syndrome: A Case in an Adult with Flea-Borne Typhus and a Review M. Kevin Dixon 1, Christopher L. Dayton 2 and Gregory M. Anstead 3,4,* 1 Baylor Scott & White Clinic, 800 Scott & White Drive, College Station, TX 77845, USA; [email protected] 2 Division of Critical Care, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA; [email protected] 3 Medical Service, South Texas Veterans Health Care System, San Antonio, TX 78229, USA 4 Division of Infectious Diseases, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA * Correspondence: [email protected]; Tel.: +1-210-567-4666; Fax: +1-210-567-4670 Received: 7 June 2020; Accepted: 24 July 2020; Published: 29 July 2020 Abstract: Parinaud’s oculoglandular syndrome (POGS) is defined as unilateral granulomatous conjunctivitis and facial lymphadenopathy. The aims of the current study are to describe a case of POGS with uveitis due to flea-borne typhus (FBT) and to present a diagnostic and therapeutic approach to POGS. The patient, a 38-year old man, presented with persistent unilateral eye pain, fever, rash, preauricular and submandibular lymphadenopathy, and laboratory findings of FBT: hyponatremia, elevated transaminase and lactate dehydrogenase levels, thrombocytopenia, and hypoalbuminemia. His condition rapidly improved after starting doxycycline. Soon after hospitalization, he was diagnosed with uveitis, which responded to topical prednisolone. To derive a diagnostic and empiric therapeutic approach to POGS, we reviewed the cases of POGS from its various causes since 1976 to discern epidemiologic clues and determine successful diagnostic techniques and therapies; we found multiple cases due to cat scratch disease (CSD; due to Bartonella henselae) (twelve), tularemia (ten), sporotrichosis (three), Rickettsia conorii (three), R.
    [Show full text]
  • Treatment of Carbapenem-Resistant Klebsiella Pneumoniae
    Review For reprint orders, please contact [email protected] Review Treatment of Expert Review of Anti-infective Therapy carbapenem-resistant © 2013 Expert Reviews Ltd Klebsiella pneumoniae: 10.1586/ERI.12.162 the state of the art 1478-7210 Expert Rev. Anti Infect. Ther. 11(2), 159–177 (2013) 1744-8336 Nicola Petrosillo1, The increasing incidence of carbapenem-resistant Klebsiella pneumoniae (CR-KP) fundamentally Maddalena alters the management of patients at risk to be colonized or infected by such microorganisms. Giannella*1, Russell Owing to the limitation in efficacy and potential for toxicity of the alternative agents, many Lewis2 and Pierluigi experts recommend using combination therapy instead of monotherapy in CR-KP-infected 2 patients. However, in the absence of well-designed comparative studies, the best combination Viale for each infection type, the continued role for carbapenems in combination therapy and when 12nd Division of Infectious Diseases, combination therapy should be started remain open questions. Herein, the authors revise current National Institute for Infectious Diseases microbiological and clinical evidences supporting combination therapy for CR-KP infections to ‘Lazzaro Spallanzani’, Rome, Italy 2Department of Medical & Surgical address some of these issues. Sciences – Alma Mater Studiorum, University of Bologna, Bologna, Italy KEYWORDS: carbapenem-resistant Klebsiella pneumoniae s CARBAPENEMASE PRODUCING STRAINS s COMBINATION *Author for correspondence: antimicrobial therapy Tel.: +39 065 517 0499 Fax: +39 065 517 0486 Life-threatening infections caused by multidrug- levofloxacin and imipenem (IMP) in vitro [8,9]. [email protected] resistant (MDR) and sometimes pan-resistant Yet, no clinical studies on combination ther- Gram-negative bacteria have increased dramati- apy in Gram-negative infections to date have cally in the last decade [1] .
    [Show full text]
  • Burkholderia Cenocepacia Integrates Cis-2-Dodecenoic Acid and Cyclic Dimeric Guanosine Monophosphate Signals to Control Virulence
    Burkholderia cenocepacia integrates cis-2-dodecenoic acid and cyclic dimeric guanosine monophosphate signals to control virulence Chunxi Yanga,b,c,d,1, Chaoyu Cuia,b,c,1, Qiumian Yea,b, Jinhong Kane, Shuna Fua,b, Shihao Songa,b, Yutong Huanga,b, Fei Hec, Lian-Hui Zhanga,c, Yantao Jiaf, Yong-Gui Gaod, Caroline S. Harwoodb,g,2, and Yinyue Denga,b,c,2 aState Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, South China Agricultural University, Guangzhou 510642, China; bGuangdong Innovative Research Team of Sociomicrobiology, College of Agriculture, South China Agricultural University, Guangzhou 510642, China; cIntegrative Microbiology Research Centre, South China Agricultural University, Guangzhou 510642, China; dSchool of Biological Sciences, Nanyang Technological University, Singapore 637551; eCenter for Crop Germplasm Resources, Institute of Crop Sciences, Chinese Academy of Agricultural Sciences, Beijing 100081, China; fState Key Laboratory of Plant Genomics, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; and gDepartment of Microbiology, University of Washington, Seattle, WA 98195 Contributed by Caroline S. Harwood, October 30, 2017 (sent for review June 1, 2017; reviewed by Maxwell J. Dow and Tim Tolker-Nielsen) Quorum sensing (QS) signals are used by bacteria to regulate N-octanoyl homoserine lactone (C8-HSL). The two QS systems biological functions in response to cell population densities. Cyclic have both distinct and overlapping effects on gene expression diguanosine monophosphate (c-di-GMP) regulates cell functions in (16, 17). response to diverse environmental chemical and physical signals One of the ways in which QS systems can act is by controlling that bacteria perceive. In Burkholderia cenocepacia, the QS signal levels of intracellular cyclic diguanosine monophosphate (c-di-GMP) receptor RpfR degrades intracellular c-di-GMP when it senses the in bacteria (18–21).
    [Show full text]
  • Cholera Transmission: the Host, Pathogen and Bacteriophage Dynamic
    REVIEWS Cholera transmission: the host, pathogen and bacteriophage dynamic Eric J. Nelson*, Jason B. Harris‡§, J. Glenn Morris Jr||, Stephen B. Calderwood‡§ and Andrew Camilli* Abstract | Zimbabwe offers the most recent example of the tragedy that befalls a country and its people when cholera strikes. The 2008–2009 outbreak rapidly spread across every province and brought rates of mortality similar to those witnessed as a consequence of cholera infections a hundred years ago. In this Review we highlight the advances that will help to unravel how interactions between the host, the bacterial pathogen and the lytic bacteriophage might propel and quench cholera outbreaks in endemic settings and in emergent epidemic regions such as Zimbabwe. 15 O antigen Diarrhoeal diseases, including cholera, are the leading progenitor O1 El Tor strain . Although the O139 sero- The outermost, repeating cause of morbidity and the second most common cause group caused devastating outbreaks in the 1990s, the El oligosaccharide portion of LPS, of death among children under 5 years of age globally1,2. Tor strain remains the dominant strain globally11,16,17. which makes up the outer It is difficult to gauge the exact morbidity and mortality An extensive body of literature describes the patho- leaflet of the outer membrane of Gram-negative bacteria. of cholera because the surveillance systems in many physiology of cholera. In brief, pathogenic strains har- developing countries are rudimentary, and many coun- bour key virulence factors that include cholera toxin18 Cholera toxin tries are hesitant to report cholera cases to the WHO and toxin co-regulated pilus (TCP)19,20, a self-binding A protein toxin produced by because of the potential negative economic impact pilus that tethers bacterial cells together21, possibly V.
    [Show full text]
  • Know Your Abcs: a Quick Guide to Reportable Infectious Diseases in Ohio
    Know Your ABCs: A Quick Guide to Reportable Infectious Diseases in Ohio From the Ohio Administrative Code Chapter 3701-3; Effective August 1, 2019 Class A: Diseases of major public health concern because of the severity of disease or potential for epidemic spread – report immediately via telephone upon recognition that a case, a suspected case, or a positive laboratory result exists. • Anthrax • Measles • Rubella (not congenital) • Viral hemorrhagic fever • Botulism, foodborne • Meningococcal disease • Severe acute respiratory (VHF), including Ebola virus • Cholera • Middle East Respiratory syndrome (SARS) disease, Lassa fever, Marburg • Diphtheria Syndrome (MERS) • Smallpox hemorrhagic fever, and • Influenza A – novel virus • Plague • Tularemia Crimean-Congo hemorrhagic infection • Rabies, human fever Any unexpected pattern of cases, suspected cases, deaths or increased incidence of any other disease of major public health concern, because of the severity of disease or potential for epidemic spread, which may indicate a newly recognized infectious agent, outbreak, epidemic, related public health hazard or act of bioterrorism. Class B: Disease of public health concern needing timely response because of potential for epidemic spread – report by the end of the next business day after the existence of a case, a suspected case, or a positive laboratory result is known. • Amebiasis • Carbapenemase-producing • Hepatitis B (perinatal) • Salmonellosis • Arboviral neuroinvasive and carbapenem-resistant • Hepatitis C (non-perinatal) • Shigellosis
    [Show full text]
  • Inverse Regulation of Vibrio Cholerae Biofilm Dispersal by Polyamine Signals Andrew a Bridges1,2, Bonnie L Bassler1,2*
    RESEARCH ARTICLE Inverse regulation of Vibrio cholerae biofilm dispersal by polyamine signals Andrew A Bridges1,2, Bonnie L Bassler1,2* 1Department of Molecular Biology, Princeton University, Princeton, United States; 2The Howard Hughes Medical Institute, Chevy Chase, United States Abstract The global pathogen Vibrio cholerae undergoes cycles of biofilm formation and dispersal in the environment and the human host. Little is understood about biofilm dispersal. Here, we show that MbaA, a periplasmic polyamine sensor, and PotD1, a polyamine importer, regulate V. cholerae biofilm dispersal. Spermidine, a commonly produced polyamine, drives V. cholerae dispersal, whereas norspermidine, an uncommon polyamine produced by vibrios, inhibits dispersal. Spermidine and norspermidine differ by one methylene group. Both polyamines control dispersal via MbaA detection in the periplasm and subsequent signal relay. Our results suggest that dispersal fails in the absence of PotD1 because endogenously produced norspermidine is not reimported, periplasmic norspermidine accumulates, and it stimulates MbaA signaling. These results suggest that V. cholerae uses MbaA to monitor environmental polyamines, blends of which potentially provide information about numbers of ‘self’ and ‘other’. This information is used to dictate whether or not to disperse from biofilms. Introduction Bacteria frequently colonize environmental habitats and infection sites by forming surface-attached multicellular communities called biofilms. Participating in the biofilm lifestyle allows bacteria to col- lectively acquire nutrients and resist threats (Flemming et al., 2016). By contrast, the individual free- *For correspondence: swimming state allows bacteria to roam. The global pathogen Vibrio cholerae undergoes repeated [email protected] rounds of clonal biofilm formation and disassembly, and both biofilm formation and biofilm exit are central to disease transmission as V.
    [Show full text]
  • Melioidosis in Northern Tanzania: an Important Cause of Febrile Illness?
    Melioidosis and serological evidence of exposure to Burkholderia pseudomallei among patients with fever, northern Tanzania Michael Maze Department of Medicine University of Otago, Christchurch Melioidosis Melioidosis caused by Burkholderia pseudomallei • Challenging to identify when cultured Soil reservoir, with human infection from contact with contaminated water Most infected people are asymptomatic: 1 clinical illness for 4,500 antibody producing exposures Febrile illness with a variety of presentations and bacteraemia is present in 40-60% of people with acute illness Estimated 89,000 deaths globally Gavin Koh CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=4975784 Laboratory diagnosis of febrile inpatients, northern Tanzania, 2007-8 (n=870) Malaria (1.6%) Bacteremia (9.8%) Mycobacteremia (1.6%) Fungemia (2.9%) Brucellosis (3.5%) Leptospirosis (8.8%) Q fever (5.0%) No diagnosis (50.1%) Spotted fever group rickettsiosis (8.0%) Typhus group rickettsiosis (0.4%) Chikungunya (7.9%) Crump PLoS Neglect Trop Dis 2013; 7: e2324 Predicted environmental suitability for B. pseudomallei in East Africa Large areas of Africa are predicted to be highly suitable for Burkholderia pseudomallei East Africa is less suitable but pockets of higher suitability including northern Tanzania Northern Tanzania Increasing suitability for B. pseudomallei Limmathurotsakul Nat Microbiol. 2016;1(1). Melioidosis epidemiology in Africa Paucity of empiric data • Scattered case reports • Report from Kilifi, Kenya identified 4 bacteraemic cases from 66,000 patients who had blood cultured1 • 5.9% seroprevalence among healthy adults in Uganda2 • No reports from Tanzania 1. Limmathurotsakul Nat Microbiol. 2016;1(1). 2. Frazer J R Army Med Corps. 1982;128(3):123-30.
    [Show full text]
  • Tick-Borne Disease Working Group 2020 Report to Congress
    2nd Report Supported by the U.S. Department of Health and Human Services • Office of the Assistant Secretary for Health Tick-Borne Disease Working Group 2020 Report to Congress Information and opinions in this report do not necessarily reflect the opinions of each member of the Working Group, the U.S. Department of Health and Human Services, or any other component of the Federal government. Table of Contents Executive Summary . .1 Chapter 4: Clinical Manifestations, Appendices . 114 Diagnosis, and Diagnostics . 28 Chapter 1: Background . 4 Appendix A. Tick-Borne Disease Congressional Action ................. 8 Chapter 5: Causes, Pathogenesis, Working Group .....................114 and Pathophysiology . 44 The Tick-Borne Disease Working Group . 8 Appendix B. Tick-Borne Disease Working Chapter 6: Treatment . 51 Group Subcommittees ...............117 Second Report: Focus and Structure . 8 Chapter 7: Clinician and Public Appendix C. Acronyms and Abbreviations 126 Chapter 2: Methods of the Education, Patient Access Working Group . .10 to Care . 59 Appendix D. 21st Century Cures Act ...128 Topic Development Briefs ............ 10 Chapter 8: Epidemiology and Appendix E. Working Group Charter. .131 Surveillance . 84 Subcommittees ..................... 10 Chapter 9: Federal Inventory . 93 Appendix F. Federal Inventory Survey . 136 Federal Inventory ....................11 Chapter 10: Public Input . 98 Appendix G. References .............149 Minority Responses ................. 13 Chapter 11: Looking Forward . .103 Chapter 3: Tick Biology, Conclusion . 112 Ecology, and Control . .14 Contributions U.S. Department of Health and Human Services James J. Berger, MS, MT(ASCP), SBB B. Kaye Hayes, MPA Working Group Members David Hughes Walker, MD (Co-Chair) Adalbeto Pérez de León, DVM, MS, PhD Leigh Ann Soltysiak, MS (Co-Chair) Kevin R.
    [Show full text]
  • IAP Guidelines on Rickettsial Diseases in Children
    G U I D E L I N E S IAP Guidelines on Rickettsial Diseases in Children NARENDRA RATHI, *ATUL KULKARNI AND #VIJAY Y EWALE; FOR INDIAN A CADEMY OF PEDIATRICS GUIDELINES ON RICKETTSIAL DISEASES IN CHILDREN COMMITTEE From Smile Healthcare, Rehabilitation and Research Foundation, Smile Institute of Child Health, Ramdaspeth, Akola; *Department of Pediatrics, Ashwini Medical College, Solapur; and #Dr Yewale Multispeciality Hospital for Children, Navi Mumbai; for Indian Academy of Pediatrics “Guidelines on Rickettsial Diseases in Children” Committee. Correspondence to: Dr Narendra Rathi, Consultant Pediatrician, Smile Healthcare, Rehabilitation & Research Foundation, Smile Institute of Child Health, Ramdaspeth, Akola, Maharashtra, India. [email protected]. Objective: To formulate practice guidelines on rickettsial diseases in children for pediatricians across India. Justification: Rickettsial diseases are increasingly being reported from various parts of India. Due to low index of suspicion, nonspecific clinical features in early course of disease, and absence of easily available, sensitive and specific diagnostic tests, these infections are difficult to diagnose. With timely diagnosis, therapy is easy, affordable and often successful. On the other hand, in endemic areas, where healthcare workers have high index of suspicion for these infections, there is rampant and irrational use of doxycycline as a therapeutic trial in patients of undifferentiated fevers. Thus, there is a need to formulate practice guidelines regarding rickettsial diseases in children in Indian context. Process: A committee was formed for preparing guidelines on rickettsial diseases in children in June 2016. A meeting of consultative committee was held in IAP office, Mumbai and scientific content was discussed. Methodology and results were scrutinized by all members and consensus was reached.
    [Show full text]
  • Klebsiella Pneumoniae Ar-Bank#0453
    KLEBSIELLA PNEUMONIAE AR-BANK#0453 Key RESISTANCE: KPC MIC (µg/ml) RESULTS AND INTERPRETATION PROPAGATION DRUG MIC INT DRUG MIC INT MEDIUM Amikacin 32 I Colistin 0.5 --- Ampicillin >32 R Doripenem >8 R Medium: Trypticase Soy Agar with 5% Sheep Blood (BAP) Ampicillin/sulbactam1 >32 R Ertapenem >8 R GROWTH CONDITIONS Aztreonam >64 R Gentamicin 1 S Temperature: 35⁰C Cefazolin >8 R Imipenem >64 R Atmosphere: Aerobic 2 Cefepime >32 R Imipenem+chelators >32 --- PROPAGATION Levofloxacin PROCEDURE Cefotaxime >64 R >8 R Cefotaxime/clavulanic 1 >32 --- Meropenem >8 R Remove the sample vial to a acid container with dry ice or a Cefoxitin >16 R Piperacillin/tazobactam1 >128 R freezer block. Keep vial on ice Ceftazidime >128 R Polymyxin B 0.5 --- or block. (Do not let vial content thaw) Ceftazidime/avibactam1 16 R3 Tetracycline 8 I Ceftazidime/clavulanic >64 --- Tigecycline 1 S3 Open vial aseptically to avoid acid1 contamination Ceftriaxone >32 R Tobramycin 16 R 1 Using a sterile loop, remove a Ciprofloxacin >8 R Trimethoprim/sulfamethoxazole >8 R small amount of frozen isolate from the top of the vial S – I –R Interpretation (INT) derived from CLSI 2016 M100 S26 1 Reflects MIC of first component Aseptically transfer the loop 2 Screen for metallo-beta-lactamase production to BAP [Rasheed et al. Emerging Infectious Diseases. 2013. 19(6):870-878] 3 Based on FDA break points Use streak plate method to isolate single colonies Incubate inverted plate at 35⁰C for 18-24 hrs. [email protected] http://www.cdc.gov/drugresistance/resistance-bank/ BIOSAFETY LEVEL 2 Appropriate safety procedures should always be used with this material.
    [Show full text]
  • Klebsiella Pneumoniae: Virulence, Biofilm and Antimicrobial Resistance
    Divya Bharathi PIDJ ESPID REPORTS AND REVIEWS PIDJ-217-384 CONTENTS Klebsiella pneumoniae Vitulence, Biofilm and Resistance in Klebsiella EDITORIAL BOARD Piperaki et al Editor: Delane Shingadia Board Members David Burgner (Melbourne, Cristiana Nascimento-Carvalho George Syrogiannopoulos XXX Australia) (Bahia, Brazil) (Larissa, Greece) Kow-Tong Chen (Tainan,Taiwan) Ville Peltola (Turku, Finland) Tobias Tenenbaum (Mannhein, Germany) Luisa Galli (Florence, Italy) Emmanuel Roilides (Thessaloniki, Marc Tebruegge (Southampton, UK) Steve Graham (Melbourne, Pediatr Infect Dis J Greece) Marceline Tutu van Furth (Amsterdam, Australia) Ira Shah (Mumbai, India) The Netherlands) Lippincott Williams & Wilkins Klebsiella pneumoniae: Virulence, Biofilm and Antimicrobial Hagerstown, MD Resistance Evangelia-Theophano Piperaki, MD, PhD,* George A. Syrogiannopoulos, MD, PhD,† Leonidas S. Tzouvelekis, MD, PhD,* and George L. Daikos, MD, PhD‡ Key Words: Klebsiella pneumoniae, virulence, ingitis in premature neonates and infants as the immune response through cytokine and biofilm, resistance well as serious infections in immunocompro- chemokine production (Fig. 1). Among the mised and malnourished children, whereas effector cells that are recruited first to the in the community, K. pneumoniae is a com- infection site are the neutrophils. Impor- mon cause of urinary tract infections among tant mediators involved in this process are lebsiella pneumoniae is a ubiquitous immunocompetent children. interleukin (IL)-8 and IL-23, which induces K Gram-negative encapsulated bacterium In recent years, most K. pneumoniae production of IL-17 that promotes granu- that resides in the mucosal surfaces of mam- infections are caused by strains termed “clas- lopoietic response.6-7 IL-12 also amplifies the mals and the environment (soil, water, etc.). sic” K. pneumoniae (cKp).
    [Show full text]
  • Laboratory Diagnostics of Rickettsia Infections in Denmark 2008–2015
    biology Article Laboratory Diagnostics of Rickettsia Infections in Denmark 2008–2015 Susanne Schjørring 1,2, Martin Tugwell Jepsen 1,3, Camilla Adler Sørensen 3,4, Palle Valentiner-Branth 5, Bjørn Kantsø 4, Randi Føns Petersen 1,4 , Ole Skovgaard 6,* and Karen A. Krogfelt 1,3,4,6,* 1 Department of Bacteria, Parasites and Fungi, Statens Serum Institut (SSI), 2300 Copenhagen, Denmark; [email protected] (S.S.); [email protected] (M.T.J.); [email protected] (R.F.P.) 2 European Program for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control (ECDC), 27180 Solnar, Sweden 3 Scandtick Innovation, Project Group, InterReg, 551 11 Jönköping, Sweden; [email protected] 4 Virus and Microbiological Special Diagnostics, Statens Serum Institut (SSI), 2300 Copenhagen, Denmark; [email protected] 5 Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), 2300 Copenhagen, Denmark; [email protected] 6 Department of Science and Environment, Roskilde University, 4000 Roskilde, Denmark * Correspondence: [email protected] (O.S.); [email protected] (K.A.K.) Received: 19 May 2020; Accepted: 15 June 2020; Published: 19 June 2020 Abstract: Rickettsiosis is a vector-borne disease caused by bacterial species in the genus Rickettsia. Ticks in Scandinavia are reported to be infected with Rickettsia, yet only a few Scandinavian human cases are described, and rickettsiosis is poorly understood. The aim of this study was to determine the prevalence of rickettsiosis in Denmark based on laboratory findings. We found that in the Danish individuals who tested positive for Rickettsia by serology, the majority (86%; 484/561) of the infections belonged to the spotted fever group.
    [Show full text]